SCHEMBL30746463

SCHEMBL30746463

CNS(=O)(=O)Nc1ccccn1

nearest known ligand 0.61

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.61
ATM Q13315 1/20 0.61
POLB P06746 1/20 0.53
KDM4E B2RXH2 10/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
LMNA P02545 2/20 0.51
ALDH1A1 P00352 6/20 0.51
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
MAPK1 P28482 1/20 0.49
HSD17B10 Q99714 2/20 0.49
HPGD P15428 1/20 0.49
RXFP1 Q9HBX9 2/20 0.48
NSD2 O96028 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31613393 0.83 TSHR (0.59) TSHRATMPOLBKDM4ESMN1; SMN2
SCHEMBL1631053 0.80 TSHR (0.65) TSHRATMPOLBKDM4ESMN1; SMN2
SCHEMBL10573841 0.79 TSHR (0.54) TSHRATMPOLBKDM4ESMN1; SMN2
Hydrochloric Acid SCHEMBL20502504 0.78 TSHR (0.62) TSHRATMPOLBKDM4ESMN1; SMN2
SCHEMBL6320584 0.77 KDM4E (0.61) TSHRATMPOLBKDM4ESMN1; SMN2
SCHEMBL23308872 0.76 TSHR (0.59) TSHRATMPOLBKDM4ESMN1; SMN2
SCHEMBL27673212 0.76 TSHR (0.59) TSHRATMPOLBKDM4ESMN1; SMN2
SCHEMBL5632154 0.76 TSHR (0.59) TSHRATMPOLBKDM4ESMN1; SMN2
SCHEMBL2104486 0.76 TSHR (0.59) TSHRATMPOLBKDM4ESMN1; SMN2
SCHEMBL14252963 0.76 TSHR (0.59) TSHRATMPOLBKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120129678-A Mitogen-activated protein kinase (MEK) inhibitors 耐斯泰德医疗公司 2025-06-10 CN disclosed
EP-4551558-A2 MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS Nested Therapeutics, Inc. (US) 2025-05-14 EP disclosed
WO-2024010925-A2 MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS NESTED THERAPEUTICS, INC. (US) 2024-01-11 WO disclosed